Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma

Current Oncology

Volumn 16, Issue 6, 2009, Pages 21-28

  Lafay Cousin, Lucie ^a   Bouffet, E ^b   Hawkins, C ^b   Amid, A ^a   Huang, A ^b   Mabbott, D J ^b  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Infants; Medulloblastoma; Neurocognitive outcome

Indexed keywords

CARBOPLATIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GROWTH HORMONE; IFOSFAMIDE; METHYLPREDNISOLONE; PREDNISONE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ACADEMIC ACHIEVEMENT; ADJUVANT THERAPY; ARTICLE; BRAIN SURGERY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOPITUITARISM; INFANT; INTELLIGENCE QUOTIENT; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LINGUISTICS; MALE; MATHEMATICS; MEDULLOBLASTOMA; METASTASIS POTENTIAL; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRESCRIPTION; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; READING; SPELLING; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; VERBAL MEMORY; VISUAL MEMORY; VISUOMOTOR COORDINATION; WECHSLER INTELLIGENCE SCALE;

EID: 72949098061     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v16i6.435     Document Type: Article

References (31)

1. Walker DA, Perilongo G, Punt JAG, Taylor RE, eds. Brain and Spinal Tumors of Childhood. London, U.K.: Arnold; 2004.
2. Walter AW, Mulhern RK, Gajjar A, et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol 1999;17:3720-3728
3. Jakacki RI, Feldman H, Jamison C, Boaz JC, Luerssen TG, Timmerman R. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma. Int J Radiat Oncol Biol Phys 2004;60:531-536
4. Copeland DR, deMoor C, Moore BD 3rd, Ater JL. Neurocognitive development of children after a cerebellar tumor in infancy: a longitudinal study. J Clin Oncol 1999;17:3476-3486
5. Kellie SJ. Chemotherapy of central nervous system tumours in infants. Childs Nerv Syst 1999;15:592-612. (Pubitemid 29493586)
6. van Eys J, Cangir A, Coody D, Smith B. mopp regimen as primary chemotherapy for brain tumors in infants. J Neurooncol 1985;3:237-243 (Pubitemid 15229832)
7. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725-1731
8. Grill J, Sainte-Rose C, Jouvet A, et al. Treatment of medulloblastoma with postoperative chemotherapy alone: an sfop prospective trial in young children. Lancet Oncol 2005;6:573-580 (Pubitemid 41051935)
9. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978-986 (Pubitemid 40349500)
10. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol 2005;23:7621-7631 (Pubitemid 46291826)
11. Moore BD 3rd, Ater JL, Copeland DR. Improved neuropsychological outcome in children with brain tumors diagnosed during infancy and treated without cranial irradiation. J Child Neurol 1992;7:281-290
12. Sands SA, van Gorp WG, Finlay JL. Pilot neuropsychological findings from a treatment regimen consisting of intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Childs Nerv Syst 1998;14:587-589
13. Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969;93:1351-1359
14. Geyer R, Levy M, Berger MS, Milstein J, Griffin B, Bleyer WA. Infants with medulloblastoma: a single institution review of survival. Neurosurgery 1991;29:707-711
15. Schmandt S, Kühl J. Chemotherapy as prophylaxis and treatment of meningosis in children less than 3 years of age with medulloblastoma. J Neurooncol 1998;38:187-192 (Pubitemid 28306206)
16. Di Rocco C, Iannelli A, Papacci F, Tamburrini G. Prognosis of medulloblastoma in infants. Childs Nerv Syst 1997;13: 388-396
17. Rivera-Luna R, López E, Rivera-Marquez H, et al. Survival of children under 3years old with medulloblastoma: a study from the Mexican Cooperative Group for Childhood Malignancies (amohp). Childs Nerv Syst 2002;18:38-42. (Pubitemid 41522965)
18. Dhall G, Grodman H, Ji L, et al. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. Pediatr Blood Cancer 2008;50:1169-1175
19. Eberhart CG, Kepner JL, Goldthwaite PT, et al. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 2002;94:552-560
20. Rutkowski S, Gerber NU, von Hoff K, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro Oncol 2008;11: 201-210
21. Rutkowski S, von Hoff K, Emser A, et al. Prognostic factors and survival of young children with medulloblastoma: an international meta-analysis [abstract]. Neuro Oncol 2008;10:437.
22. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999;17:832-845
23. Halperin EC, Watson DM, George SL. Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma. Cancer 2001;91:1444-1450
24. Sanders RP, Onar A, Boyett JM, et al. M1 medulloblastoma: high risk at any age. J Neurooncol 2008;90:351-355
25. Thorarinsdottir HK, Rood B, Kamani N, et al. Outcome for children < 4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer 2007;48:278-284
26. Chi SN, Gardner SL, Levy AS, et al. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 2004;22:4881-4887
27. Fouladi M, Gilger E, Kocak M, et al. Intellectual and functional outcome of children 3 years old or younger who have cns malignancies. J Clin Oncol 2005;23:7152-7160
28. Mulhern RK, Reddick WE, Palmer SL, et al. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol 1999;46:834-841
29. Dennis M, Spiegler BJ, Hetherington CR, Greenberg ML. Neuropsychological sequelae of the treatment of children with medulloblastoma. J Neurooncol 1996;29:91-101. (Pubitemid 26193508)
30. Packer RJ, Sutton LN, Atkins TE, et al. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. J Neurosurg 1989;70:707-713
31. Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 2004;22:706-713 (Pubitemid 41095075)